Reducible Polyethylenimine Nanoparticles for Efficient siRNA Delivery in Corneal Neovascularization Therapy
Authors:
- 9 August 2016
- journal article
- research article
- Published by Wiley in Macromolecular Bioscience
- Vol. 16 (11) , 1583-1597
Abstract
The aim of this study is to establish the safe and effective ocular delivery system of therapeutic small interfering RNA (siRNA) in corneal neovascularization therapy. The major hurdle present in siRNA-based corneal neovascularization (CNV) therapy is severe cytotoxicity caused by repetitive drug treatment. A reducible branched polyethylenimine (rBPEI)-based nanoparticle (NP) system is utilized as a new siRNA carrier as a hope for CNV therapy. The thiolated BPEI is readily self-crosslinked in mild conditions to make high molecular weight rBPEI thus allowing the creation of stable siRNA/rBPEI nanoparticles (siRNA-rBPEI-NPs). In the therapeutic region, the rBPEI polymeric matrix is effectively degraded into nontoxic LMW BPEI inside the reductive cytosol causing the rapid release of the encapsulated siRNA into the cytosol to carry out its function. The fluorescent-labeled siRNA-rBPEI-NPs can release siRNA into the entire corneal region after subconjuctival injection into the eye of Sprague Dawley rats thus confirming the proof of concept of this system.Keywords
Funding Information
- National Research Foundation of Korea (2013K1A1A2A02050115, 2012K1A1A2A01055811)
- Korea Institute of Science and Technology
This publication has 33 references indexed in Scilit:
- Ocular Delivery of pRNA Nanoparticles: Distribution and Clearance After Subconjunctival InjectionPharmaceutical Research, 2013
- Nanotechnology in Corneal Neovascularization Therapy—A ReviewJournal of Ocular Pharmacology and Therapeutics, 2013
- Corneal Neovascularization: An Anti-VEGF Therapy ReviewSurvey of Ophthalmology, 2012
- Nanoparticle-Mediated Delivery of shRNA.VEGF-A Plasmids Regresses Corneal NeovascularizationInvestigative Ophthalmology & Visual Science, 2012
- Emerging techniques to treat corneal neovascularisationEye, 2011
- Knocking down barriers: advances in siRNA deliveryNature Reviews Drug Discovery, 2009
- Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imagingNucleic Acids Research, 2006
- Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disordersGene Therapy, 2005
- Inhibition of Ocular Angiogenesis by siRNA Targeting Vascular Endothelial Growth Factor Pathway GenesThe American Journal of Pathology, 2004
- RNA interferenceNature, 2002